Podcasts about sobi

Arrested in Thailand.Thrown in a jail cell with the Googan Squad. And that's just one of the many stories that get revealed. In this episode of the Mercer Podcast, Sam Sobi goes way beyond fishing. We talk about the dreams that built him, the setbacks that tested him, giant bass, bugling elk, true love… and the moments that shaped him But first we have the return of Jake's Take. Bassmaster videographer Jake Latendresse breaks down what really happened behind the scenes from inside the boat with eventual champion Hank Cherry, Trey McKinney, Bryant Smith, and Hunter Shryock. If you love the Elite Series but wish you could hear the stuff that never makes TV — this is it. Raw stories. Real laughs. Zero script & as always awkwardly honest!

The boys are all back for this one and it's another doozy! Bart, Pink, and Sobi dive into a bit about what they've had going on, including a good buddies wedding and some fishing. We chat about the start of the Bassmaster Season and how Fantasy Fishing has kicked off, with some good laughs as usual.We then bring on Drew Gill, to chat about his surge into the spotlight of bass fishing the past few years. An incredibly enlightening discussion filled with awesome information and fun.It's a great one! Don't miss out.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Arrested in Thailand.Thrown in a jail cell with the Googan Squad. And that's just one of the many stories that get revealed. In this episode of the Mercer Podcast, Sam Sobi goes way beyond fishing. We talk about the dreams that built him, the setbacks that tested him, giant bass, bugling elk, true love… and the moments that shaped him But first we have the return of Jake's Take. Bassmaster videographer Jake Latendresse breaks down what really happened behind the scenes from inside the boat with eventual champion Hank Cherry, Trey McKinney, Bryant Smith, and Hunter Shryock. If you love the Elite Series but wish you could hear the stuff that never makes TV — this is it. Raw stories. Real laughs. Zero script & as always awkwardly honest!

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. In today's episode, we delve into the dynamic landscape of these industries, exploring ambitious strategic plans, regulatory hurdles, scientific breakthroughs, and emerging trends that are shaping the future of healthcare.Let's begin with AstraZeneca, which has set an ambitious target to achieve $80 billion in revenue by 2030. This goal reflects their intention to bring over 25 blockbuster drugs to market, underscoring a commitment to innovation and expansion in their therapeutic portfolio. The focus on cutting-edge research is not just a strategy for growth but also a sign of the broader industry trend where large pharmaceutical companies pursue high-value targets to strengthen their market positions. AstraZeneca is also making strides in the weight-loss market with its new candidate elecoglipron, undergoing an extensive late-stage program to evaluate its efficacy as a monotherapy and in combination treatments for various indications. This development positions AstraZeneca competitively in the burgeoning sector, offering a novel therapeutic option for obesity management.Meanwhile, CSL Limited is undergoing a leadership transition. CEO Paul McKenzie has stepped down under pressure, and Gordon Naylor has been appointed as interim chief. This change highlights the critical role of strategic leadership in navigating industry challenges and maintaining growth trajectories amidst a rapidly shifting market landscape.In a display of financial success, Novartis reported a record-breaking performance for 2025. This achievement led to a 30% increase in CEO Vas Narasimhan's compensation, reaching $32 million. The company's robust financial health is attributed to advancing innovative treatments targeting unmet medical needs, emphasizing how achieving innovation milestones can significantly enhance corporate valuation and leadership rewards.Incyte is preparing for the patent expiration of its blood cancer drug Jakafi in 2028 by focusing on Opzelura, a topical cream that has witnessed a 33% sales increase from the previous year. With sales reaching $678 million, Opzelura's success highlights Incyte's strategic pivot to diversify its product offerings and mitigate risks associated with patent cliffs. This exemplifies how companies must continuously innovate and adapt to maintain competitive advantages.Moderna has entered into a long-term agreement with Mexico to ensure local mRNA vaccine supply through technology transfer to Laboratorios Liomont. This partnership extends Moderna's global footprint and underscores the critical role of mRNA technology in pandemic preparedness and vaccine accessibility, reinforcing its transformative impact on public health strategies.Regulatory landscapes have also seen notable activity. The FDA issued untitled letters concerning potentially misleading drug advertisements from companies like Novo Nordisk, Argenx, and Sobi. Such actions emphasize regulatory vigilance in marketing practices. Additionally, Lilly's Kinsunla failed to secure approval in Scotland, while Regenxbio faced rejection for its gene therapy for Hunter syndrome. These regulatory hurdles highlight the rigorous oversight pharma companies face and the complex pathways drugs must navigate before market approval.Collaborations within the industry are proving crucial for innovation. Merck's collaboration with Calla Lily Clinical Care aims to enhance delivery systems for vaginal therapeutics. Similarly, Bristol Myers Squibb's partnership with Evinova focuses on integrating AI into clinical development processes. These alliances reflect an industry-wide emphasis on leveraging technology to improve drug delivery efficiency and streamline clinical trial operations.Shifting our focus now to scientific advancements and clinical trial results that aSupport the show

Konservatiivses vestlussaates "Vaba sõna" räägivad EKRE poliitikud Evelin ja Anti Poolamets seekord  umbusaldusavaldusest põllumajandusminister Terrasele, e-valimiste hallidest varjunditest ja sellest, kuidas ajakirjanike ajusid tahetakse suure raha eest pesema hakata.

The boys are back! We've got a good 'ol fashion solo Pod. This time we're diving into some stories from the road in South Dakota, PTB Fan Questions from our 100th Episode, a little Chat PTB, and finally The Weigh in of "Best Things in a Bottle"Hang tight, it's a good one!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we delve into some of the most significant events shaping the industry, from innovative drug formulations and regulatory challenges to the dynamic IPO landscape and clinical trial outcomes.Starting with Novo Nordisk, their oral formulation of Wegovy is witnessing substantial uptake, showcasing a strong demand for novel obesity treatments. This rapid adoption underscores a competitive environment where companies like Eli Lilly, with its Zepbound launch, are vying for market share. The introduction of innovative delivery methods in obesity management not only drives immediate commercial success but also highlights a critical area of therapeutic advancement due to the rising global prevalence of obesity.From a regulatory perspective, alignment with bodies like the FDA remains crucial. Companies such as Beam Therapeutics and Cabaletta Bio emphasize this at events like the J.P. Morgan Healthcare Conference, highlighting the importance of clear regulatory pathways in ensuring the successful approval of promising therapies. Conversely, Atara Biotherapeutics' recent setback with an unexpected FDA rejection demonstrates the unpredictability inherent in regulatory processes, which can significantly impact drug development timelines.The IPO market in biotech remains vibrant despite broader market uncertainties. Noteworthy are Agomab Therapeutics and Spyglass Pharma, each preparing for substantial public offerings. Agomab focuses on ALK5 inhibitors for inflammatory diseases, while Spyglass advances drug delivery implants for chronic eye conditions. This wave of IPOs highlights investor confidence in innovative therapies that address unmet medical needs and reflects a broader trend toward precision medicine and novel treatment modalities.In clinical research, AbbVie and Genmab faced a setback when their bispecific antibody failed to meet a crucial endpoint in a Phase III lymphoma study. Such challenges underscore the high stakes involved in oncology drug development, where successes can significantly alter treatment paradigms, yet failures remind us of the inherent risks.Turning to Alzheimer's disease, there is palpable excitement around next-generation treatments under investigation. These candidates promise to reshape the landscape by offering new hope in a field where effective therapies are desperately needed. This is complemented by advancements in manufacturing capabilities recognized as essential to strategic planning beyond 2026, ensuring that production processes can scale efficiently to meet global demands.On the workforce front, Takeda's decision to reduce its U.S. headcount, impacting its neurology teams, reflects industry trends where resource allocation is increasingly focused on core growth areas. Such strategic recalibrations are part and parcel of navigating competitive pressures and evolving market demands.In another realm, ImmunityBio's Phase 1 results for its CD19 CAR-NK cell therapy offer promising insights into innovative oncology approaches. The use of natural killer cells engineered with chimeric antigen receptors could revolutionize cancer treatment by providing targeted therapeutic options for hematological malignancies and potentially solid tumors.Regulatory approvals also continue to shape industry dynamics. SOBI's Aspaveli receiving EU approval for rare kidney diseases marks significant progress in complement inhibition therapies. Meanwhile, Bayer's Eylea approval for retinal vein occlusion-related visual impairment reinforces the vital role of VEGF inhibitors in ophthalmology.Strategic collaborations are also making headlines, as seen with Abelzeta and AstraZeneca's expanded partnership on GPC3 CAR-T therapy through an acquisition focused on China rights. This move illustrates the global interest inSupport the show

Good morning from Pharma Daily: the podcast that brings you the most important developments in the pharmaceutical and biotech world. Today, we're diving deep into the latest breakthroughs, regulatory updates, and industry trends shaping the future of healthcare.Let's start with Johnson & Johnson's recent achievement in precision oncology. They've secured a second FDA approval for Akeega, a combination therapy that merges J&J's Zytiga with GSK's Zejula. This innovative approach targets BRCA2-mutated metastatic castration-sensitive prostate cancer, marking a significant advancement in personalized medicine. This approval not only highlights the progress in tailored treatment strategies but also sets a new benchmark for therapeutic innovation in this particular cancer subset.Moving on to cardiovascular health, Cincinnati's LIB Therapeutics has introduced Lerochol, a third-generation PCSK9 inhibitor designed to lower cholesterol. Unlike its predecessors, Lerochol offers simplified administration, potentially improving patient adherence and outcomes. This approval is part of a broader effort to refine lipid-lowering therapies and better address cardiovascular diseases.In a groundbreaking development for heart rhythm disorders, Milestone Pharmaceuticals has received FDA approval for Cardamyst, a nasal spray that patients can self-administer to manage paroxysmal supraventricular tachycardia (PSVT). This novel treatment option empowers patients with an on-demand solution to control their heart rhythms, significantly enhancing their quality of life.Turning to infectious diseases, Innoviva's Nuzolvence has been approved as a much-needed new treatment for gonorrhea, the first in over three decades following GSK's Blujepa. This marks an essential step forward in combating antibiotic-resistant sexually transmitted infections and highlights the urgency of developing new antimicrobial agents.However, not all ventures have met with success. Argenx recently halted studies of its drug Vyvgart in thyroid eye disease after disappointing trial results. This decision underscores the inherent challenges and risks involved in drug development, particularly when tackling complex autoimmune conditions.Sanofi has faced its own hurdles with Tolebrutinib after experiencing both FDA delays and trial misses in non-relapsing secondary progressive multiple sclerosis. These setbacks emphasize the intricacies of bringing innovative therapies to market and the critical importance of robust clinical trial design and regulatory strategy.Strategic collaborations are also playing a pivotal role in the industry. Adaptive Biotechnologies has partnered with Pfizer to leverage its T-cell receptor discovery technology. Meanwhile, Dren Bio is expanding its collaboration with Sanofi to develop next-generation B-cell depleting therapies for autoimmune diseases. These alliances reflect an increasing trend towards collaborative innovation to harness cutting-edge technologies.Another strategic move comes from Sobi, which has acquired Arthrosi Therapeutics for $950 million to bolster its portfolio with phase 3 gout treatments. This acquisition bypasses traditional IPO routes and showcases evolving deal-making strategies within biopharma.In another exciting development, Kyverna Therapeutics is on the verge of securing the first-in-class CAR-T therapy approval for autoimmune diseases following promising trial results with its CD19 agent. This could herald a new era in autoimmune disease management through cellular therapies.In regulatory news beyond pharmaceuticals, former President Donald Trump signed an executive order establishing a unified federal framework for artificial intelligence (AI). This aims to streamline AI regulation across states and could accelerate AI integration into various sectors, including healthcare.These developments collectively represent pivotal moments in the pharmaceutical and Support the show

O světlo v Klášterních zahradách se postaral tým chrudimské besedy pod vedením ředitele Martina Dytrta.

After a brief delay, the boys are back for another episode of PTB. We've got Sobi and Bart holding down the fort, as Pink is just getting back from a Western Hunt that we will hear more about soon. Sobi and Bart catch up about what's been going on in their lives, including Bart heading to the Pacific Northwest with his family.Then, the boys have on one of their best friends, Brent Relopez to chat about the beginning of Team Yukon Outdoors and some stories from all of their starts in the outdoor industry.After that we do a nice little "Geared Up" segment, and end with some storytime from Sobi, as he finally sealed the deal on his Deer Hunting Season.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Pinkalla and Sobi break down what's been happening in the woods. The boys have been on the hunt for whitetails. You can talk big buck hunting without bringing in the Herd Bull, Chancy Walters, who came face to face with one of the Biggest whitetails to ever hit the dirt. This one is loaded from front to back with some epic stories from the wilds of Alaska to the timber of Kansas. Stolski checks in from the Barn and buddy Hays stops in to talk fall fishing. Round this one out with a classic Weigh-in of: Things that install turn around a bad day.Don't miss a moment of this one!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

I USA pekar terminerna mot en grön öppning efter att börserna på Wall Street avslutade veckan med uppgångar I Asien stiger dom ledande indexen I Sverige ser handeln på Stockholmsbörsen ut att inleda nedåt när Sobi kommit med en omvänd vinstvarning där resultatet väntas stiga över 10 procent.

We've got a full squad back in the house for another OG Pod Episode as Bart, Pink, and Sobi catch up on all that's been going on in their lives lately. A lot of fishing, some hunting, and traveling all over the country this fall.We chat about some Hot Takes that the PTB fan community submitted on our Social Channels and ultimately end up recapping the events from Bart's wedding.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We've got the whole crew back for another Episode of PTB and this one is an old school episode. No Guests, just Bart, Pinkalla, and Sobi to catch up on everything that's been going on in their lives. We're a few days away from Bart's wedding and the boys are hyped, there's been a lot of fishing going on, and Pinkalla is home from his Western hunting excursion with some incredible stories as usual.It's another great one!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We are back for another Episode of PTB and while Pinkalla is out of town on an Elk Hunt, Bart and Sobi hold down the fort. We kickoff the episode with some banter about what we've been up to lately, then we're off to the races.Brett Carlson joins the Podcast to chat about his career in the fishing industry, stemming back to early days with FLW Outdoors, ghost writing for most of the outdoor publications you read, and becoming the voice of Tour Level Gold. We dive deep into the walleye fishing industry, where it's been and where it's headed.Then we welcome on NWT Angler of the Year, South Dakota's finest, Duey Hjelm to chat about his career that has exploded as of late, his role with Tour Level Gold, and how he started in the walleye world.This episode is LOADED with great stories, insight, and even some educational topics. It's a great one.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

The accredited CME program highlights the latest clinical research about iTTP, a rare thrombotic disorder. Led by Shruti Chaturvedi, MD, this activity provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with iTTP. This program is supported by an educational grant from Sanofi.To receive CME credit, go to https://checkrare.com/learning/p-isth2025-module3-immune-thrombotic-thrombocytopenic-purpura-ittp-clinical-research-highlights/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in iTTP. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with iTTP and its clinical relevance. Shruti Chaturvedi, MDAssistant Professor of MedicineJohns Hopkins Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Chaturvedi discloses the following relevant financial relationships with ineligible companies:Scientific Advisory Board/Consultant: Sanofi, Takeda, Sobi, argenx, Star Pharma, RallyBio, Novartis, AlexionGrant/Research Support: Sanofi, Sobi, argenx Other Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information. Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days. PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

This accredited CME program highlights the latest clinical research about immune thrombocytopenia (ITP), a rare thrombotic disorder. Led by Shruti Chaturvedi, MD, this program provides a summary of clinically relevant data presented at the International Society of Thrombosis and Haemostatis Congress (ISTH 2025) that can enhance the care of patients with ITP. This program is supported by an educational grant from Sanofi.To receive CME credit, go to https://checkrare.com/learning/p-isth2025-module2-immune-thrombocytopenia-clinical-research-highlights/Target AudienceThis activity has been designed to meet the educational needs of physicians specializing in ITP. Other members of the care team may also participate.Learning ObjectivesAfter participating in the activity, learners should be better able to:Describe the latest research being presented to better manage individuals with ITP and its clinical relevance.FacultyShruti Chaturvedi, MDAssistant Professor of Medicine,Johns Hopkins Disclosure StatementAccording to the disclosure policy of the Academy, all faculty, planning committee members, editors, managers and other individuals who are in a position to control content are required to disclose any relationships with any ineligible company(ies). The existence of these relationships is not viewed as implying bias or decreasing the value of the activity. Clinical content has been reviewed for fair balance and scientific objectivity, and all of the relevant financial relationships listed for these individuals have been mitigated. Disclosure of relevant financial relationships are as follows:Faculty Educator/PlannerDr. Chaturvedi discloses the following relevant financial relationships with ineligible companies:Scientific Advisory Board/Consultant: Sanofi, Takeda, Sobi, argenx, Star Pharma, RallyBio, Novartis, AlexionGrant/Research Support: Sanofi, Sobi, argenx Other Planners for this activity have no relevant financial relationships with any ineligible companies. This activity will review off-label or investigational information. The opinions expressed in this educational activity are those of the faculty, and do not represent those of the Academy or CheckRare CE. This activity is intended as a supplement to existing knowledge, published information, and practice guidelines. Learners should appraise the information presented critically, and draw conclusions only after careful consideration of all available scientific information.Accreditation and Credit DesignationIn support of improving patient care, this activity has been planned and implemented by American Academy of CME, Inc. and CheckRare CE. American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.PhysiciansAmerican Academy of CME, Inc., designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Other HCPsOther members of the care team will receive a certificate of participation. There are no fees to participate in the activity. Participants must review the activity information including the learning objectives and disclosure statements, as well as the content of the activity. To receive CME credit for your participation, please complete the pre and post-program assessments. Your certificate will be emailed to you within 30 days. PrivacyFor more information about the American Academy of CME privacy policy, please access http://www.academycme.org/privacy.htm  For more information about CheckRare's privacy policy, please access https://checkrare.com/privacy/ContactFor any questions, please contact: CEServices@academycme.orgCopyright© 2025. This CME-certified activity is held as copyrighted © by American Academy of CME and CheckRare CE. Through this notice, the Academy and CheckRare CE grant permission of its use for educational purposes only. These materials may not be used, in whole or in part, for any commercial purposes without prior permission in writing from the copyright owner(s).

Vláda robí zahraničnú politiku nie pre Slovensko, ale pre 20 percent voličov Smeru. Slovensku tým podľa bývalého veľvyslanca v Londýne Róbert Ondrejcsáka škodí, konkrétne tým, že zneisťuje budúcich investorov. Tí jednoducho neinvestujú peniaze na Slovensku, ak počúvajú predstaviteľov vládnych strán spochybňovať našu európsku budúcnosť. To môže spôsobiť miliardové škody. Čo môže pokaziť ako veľvyslanec Miroslav Radačovský na Cypre?V podcaste s Róbertom Ondrejcsákom sa dozviete:–⁠⁠⁠⁠⁠⁠ od 1. minúty –⁠⁠⁠⁠⁠⁠ že tri stretnutia Roberta Fica s Putinom sú hanba a zahraničná politika len pre jeho voličov;–⁠⁠⁠⁠⁠⁠ od 3:00 –⁠⁠⁠⁠⁠⁠ ako Rusi nedodržali to, čo sľúbili Maďarom v súvislosti s ich jadrovými elektrárňami;–⁠⁠⁠⁠⁠⁠ po 6:00 –⁠⁠⁠⁠⁠⁠ ako nás budú súdiť podľa toho, s kým sa stretávame;–⁠⁠⁠⁠⁠⁠ od 7:00 –⁠⁠⁠⁠⁠⁠ ako konkrétne nám škodí Ficova politika orientovaná iba na východ;–⁠⁠⁠⁠⁠⁠ po 8:00 –⁠⁠⁠⁠⁠⁠ ako sa zahraničná politika premietne do života bežného Slováka;–⁠⁠⁠⁠⁠⁠ od 10:00 –⁠⁠⁠⁠⁠⁠ že spochybňovanie európskej budúcnosti Slovenska z úst smerákov nám môže spôsobiť miliardové škody;–⁠⁠⁠⁠⁠⁠ po 12:00 –⁠⁠⁠⁠⁠⁠ či za jeho pôsobenia v Londýne Veľká Británia ovplyvňovala voľby na Slovensku;–⁠⁠⁠⁠⁠⁠ od 13:00 –⁠⁠⁠⁠⁠⁠ ako boli Ficove výmysly o ovplyvňovaní volieb vnímané v Londýne;–⁠⁠⁠⁠⁠⁠ po 17:00 –⁠⁠⁠⁠⁠⁠ čo je ovplyvňovanie volieb a čo je podpora demokracie;–⁠⁠⁠⁠⁠⁠ po 24:00 –⁠⁠⁠⁠⁠⁠ ako vyzeral vpád šťuky Blanára do rybníka so slovenskými diplomatmi;–⁠⁠⁠⁠⁠⁠ od 30:00 –⁠⁠⁠⁠⁠⁠ čo dokáže pokaziť Miroslav Radačovský ako veľvyslanec na Cypre;–⁠⁠⁠⁠⁠⁠ po 33:00 –⁠⁠⁠⁠⁠⁠ či Robert Kaliňák svojimi nákupmi posilňuje armádu.

Vláda robí zahraničnú politiku nie pre Slovensko, ale pre 20 percent voličov Smeru. Slovensku tým podľa bývalého veľvyslanca v Londýne Róbert Ondrejcsáka škodí, konkrétne tým, že zneisťuje budúcich investorov. Tí jednoducho neinvestujú peniaze na Slovensku, ak počúvajú predstaviteľov vládnych strán spochybňovať našu európsku budúcnosť. To môže spôsobiť miliardové škody. Čo môže pokaziť ako veľvyslanec Miroslav Radačovský na Cypre?V podcaste s Róbertom Ondrejcsákom sa dozviete:–⁠⁠⁠⁠⁠⁠ od 1. minúty –⁠⁠⁠⁠⁠⁠ že tri stretnutia Roberta Fica s Putinom sú hanba a zahraničná politika len pre jeho voličov;–⁠⁠⁠⁠⁠⁠ od 3:00 –⁠⁠⁠⁠⁠⁠ ako Rusi nedodržali to, čo sľúbili Maďarom v súvislosti s ich jadrovými elektrárňami;–⁠⁠⁠⁠⁠⁠ po 6:00 –⁠⁠⁠⁠⁠⁠ ako nás budú súdiť podľa toho, s kým sa stretávame;–⁠⁠⁠⁠⁠⁠ od 7:00 –⁠⁠⁠⁠⁠⁠ ako konkrétne nám škodí Ficova politika orientovaná iba na východ;–⁠⁠⁠⁠⁠⁠ po 8:00 –⁠⁠⁠⁠⁠⁠ ako sa zahraničná politika premietne do života bežného Slováka;–⁠⁠⁠⁠⁠⁠ od 10:00 –⁠⁠⁠⁠⁠⁠ že spochybňovanie európskej budúcnosti Slovenska z úst smerákov nám môže spôsobiť miliardové škody;–⁠⁠⁠⁠⁠⁠ po 12:00 –⁠⁠⁠⁠⁠⁠ či za jeho pôsobenia v Londýne Veľká Británia ovplyvňovala voľby na Slovensku;–⁠⁠⁠⁠⁠⁠ od 13:00 –⁠⁠⁠⁠⁠⁠ ako boli Ficove výmysly o ovplyvňovaní volieb vnímané v Londýne;–⁠⁠⁠⁠⁠⁠ po 17:00 –⁠⁠⁠⁠⁠⁠ čo je ovplyvňovanie volieb a čo je podpora demokracie;–⁠⁠⁠⁠⁠⁠ po 24:00 –⁠⁠⁠⁠⁠⁠ ako vyzeral vpád šťuky Blanára do rybníka so slovenskými diplomatmi;–⁠⁠⁠⁠⁠⁠ od 30:00 –⁠⁠⁠⁠⁠⁠ čo dokáže pokaziť Miroslav Radačovský ako veľvyslanec na Cypre;–⁠⁠⁠⁠⁠⁠ po 33:00 –⁠⁠⁠⁠⁠⁠ či Robert Kaliňák svojimi nákupmi posilňuje armádu.

To get live links to the music we play and resources we offer, visit www.WOSPodcast.comThis show includes the following songs:Lauralie - Think About Woman FOLLOW ON SPOTIFYJessica Woodlee - Exit Interview FOLLOW ON SPOTIFYLibby Ember - Alibi FOLLOW ON SPOTIFYShairis - Eden Never Saw FOLLOW ON SPOTIFYClancy - i killed my therapist FOLLOW ON SPOTIFYKailey Conner - Existential Dread FOLLOW ON SPOTIFYSobi - Superstar FOLLOW ON SPOTIFYMozaandNancie - Goodbye FOLLOW ON SPOTIFYJemily Rime - I Don't Think About You FOLLOW ON SPOTIFYLittle Warrior - A Thousand Deaths (By Different Knives) FOLLOW ON SPOTIFYNatalie Groves - Time to Choose Myself FOLLOW ON SPOTIFYClare Cordell - Big Girl FOLLOW ON SPOTIFYLauren Spring - Self Soother FOLLOW ON SPOTIFYBENTO - Paralyzed FOLLOW ON SPOTIFYdaisy - WILD CHILDS FOLLOW ON YOUTUBEFor Music Biz Resources Visit www.FEMusician.com and www.ProfitableMusician.comVisit our Sponsor Profitable Musician Newsletter at profitablemusician.com/joinVisit our Sponsor Cathy Wood at cathywoodmusic.comVisit our Sponsor 39 Streams of Income at profitablemusician.com/incomeVisit www.wosradio.com for more details and to submit music to our review board for consideration.Visit our resources for Indie Artists: https://www.wosradio.com/resourcesBecome more Profitable in just 3 minutes per day. http://profitablemusician.com/join

Summer has come to an end and our schedules are starting to free back up, so needless to say we are BACK for another Episode of PTB. This week we've got a full house with Bart, Pink, and Sobi on the Pod. We immediately launch into chatting with our friend Matt Pangrac about the BASS FFS ruling and what this means for BASS and professional fishing.After this rabbit hole, it's the return of the Montana man, and worldwide fishing guide, our buddy, Wild Bill Stolski.This is a great one! Don't forget to leave a rating and review for us.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Welcome to Episode 082 of the Beyond the Diagnosis Podcast. In this episode, we're exploring the personal journeys of patients and families navigating the complex world of HLH and delving into the transformative power of collaboration between organizations dedicated to advancing physician education on rare diseases. Tune in to learn how as the patient voice is brought into the conversation, these collaborative efforts are shaping the future of healthcare and the opportunity we had to partner with NORD and Sobi to create a course through MedLive that provides continuing medical education to physicians all over the world. Let us know what you think! Leave us a review, drop us a comment or share an idea for a future podcast with us at podcast@histio.org.   Take a screenshot and tag us @histiocytosis_association on Instagram. We'd love to hear your feedback!  Be sure to subscribe so you can be notified the moment a new episode of Beyond the Diagnosis is released.  Resources mentioned in the podcast: Access the CME Course Sign up for the Histio Blue Ribbon Run  Follow the Histiocytosis Association on social media: Facebook: https://www.facebook.com/histio Twitter: @histiocytosis Instagram: histiocytosis_association YouTube: https://www.youtube.com/histiocytosisassoc  Music: “Heroes” by Noah Smith Sound effects from Pixabay 

We are back after a brief delay, as we were all absolutely slammed busy the past few weeks, but we've got a full squad back this week and ready to rock. Sobi, Bart, and Pink all catch up on a bit of what's been going on in their lives. Tourney Tuesday has gotten hot and heavy, and we are starting to begin the transition into hunting season.We then bring on friend of the Podcast, Owen Wilcox, to dive into the NWT Season, what it's been like being a part of Tour Level Gold, and the craziness that is professional walleye fishing. Then of course, we have to dive into Western Hunting with Own, as his family owns and operates Montana Hunting Company.This one is loaded with incredible stories, a lot of fun, and plenty of side tangents.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Are you a different animal and the same beast?Przekonajmy się!Cześć! Mam na imię Andrzej. Lubię nazywać emocje. Tworzę piosenki, historie, scenariusze, książki. Z jedną premierą fabularną audio debiutowałem na TOP3 Podcasty Spotify Polska. Oprócz tego jestem psychologiem biznesu szukającym sposobów na lepsze dbanie o siebie i innych w późnym kapitalizmie. Stworzyłem koncepcję osoby wysokosprawczej. Cztery razy zaproszono mnie na TEDx.---Wszystkie linki znajdziesz tutaj: ⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://andrzejtucholski.pl/⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

We've got a full squad back in the house! Sobi, Bart, and Pink catch up on a ton that's been going on in their lives lately and hear a bit about how Sobi's last Champions Tour event went. Then we have on an incredible guest, NicoleLynnOutdoors. Nicole is a multi-species badass who specializes in catching muskies out of a kayak. We have an awesome chat with her about all things fishing, and how she got into it all.Next, we dive into a little bit of "What in the World is Going On!?" and also chat a little bit about Professional Bass Fishing, as well as answer some PTB Fan Questions.We end with The Weigh In of "Things That Are Hard To Do On The First Try"This is a banger, and it feels great for the full squad to be back.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Bob McLay, General Manager of Sobi Canada, gives insights into stewarding rare drug therapies, KOL advocacy and the future of preventative medicine. Get full access to NPC Healthbiz Weekly at healthbiz.substack.com/subscribe

„Duchoň mohol veľa vecí odmietnuť, ale neurobil to a zakryl to tým, že chce predsa iba spievať, užívať si život a ostatné nerieši. Takých ľudí tu máme aj dnes, vrátane politikov, ktorí si len užívajú,“ hovorí režisér Peter Bebjak.

Gaj in njegova mama sta prepričana, da lahko sobo povečata. Le kako jima bo to uspelo? Pripoveduje: Robert Waltl. Napisala: Bina Štampe Žmavc. Posneto v studiih Radia Slovenija 1992.

We've got a short deck this week but an AWESOME Episode for all of you. Bart and Sobi catch up on what's been a pretty hectic and crazy month of June; Sobi has barely been home and he hits the road AGAIN tomorrow.Then we bring on a great friend, Nick Lindner, to chat about what it was like growing up as a Lindner, the world of Walleye fishing, and then we dive into the DEPTHS of YouTube and what it's like being a content creator.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Tomáš Soukup, rizikový inžinier z Premium poisťovne, upozorňuje, že ani malé podniky nie sú imúnne voči katastrofickým udalostiam. Nedostatok poistenia či podcenenie rizík môže mať likvidačné následky nielen pre firmu, ale aj pre jej okolie. Rozhovor vznikol v spolupráci s komerčným partnerom

När IG Börssnack har säsongsavslutning tipsar marknadsanalytikern Patrick Thomenius om hur du handlar bäst i sommar.Det blir också en stor genomgång av casen – däribland Avtech, Neonode, Shelly Group och SOBI. Till sist en trade från proffset ”Mikrit”.Läs mer om IG: https://www.ig.com/X: https://twitter.com/igsverigeInstagram: https://www.instagram.com/igsverige/Facebook: https://www.facebook.com/IGSverige​LinkedIn: https://www.linkedin.com/company/igsverige/Optioner är komplexa finansiella instrument. Handel med dessa instrument medför en hög risk för snabb förlust av pengar. CFD-kontrakt är komplexa instrument som innebär stor risk för snabba förluster på grund av hävstången. 75 % av alla icke-professionella kunder förlorar pengar på CFD-handel hos den här leverantören. Du bör tänka efter om du förstår hur CFD-kontrakt fungerar, och om du har råd med den stora risken för att förlora dina pengar.

I veckans IG Börssnack diskuteras vad Donald Trumps skattesänkningar får för konsekvenser för bolagen – de som gynnas och de som missgynnas. På agendan står också de rapporterande USA-bolagen Nvidia och Costco. Till sist ett case i det svenska Läkemedelsbolaget SOBI och en trade i kryptobörsen Coinbase.Läs mer om IG: https://www.ig.com/X: https://twitter.com/igsverigeInstagram: https://www.instagram.com/igsverige/Facebook: https://www.facebook.com/IGSverige​LinkedIn: https://www.linkedin.com/company/igsverige/Optioner är komplexa finansiella instrument. Handel med dessa instrument medför en hög risk för snabb förlust av pengar. CFD-kontrakt är komplexa instrument som innebär stor risk för snabba förluster på grund av hävstången. 75 % av alla icke-professionella kunder förlorar pengar på CFD-handel hos den här leverantören. Du bör tänka efter om du förstår hur CFD-kontrakt fungerar, och om du har råd med den stora risken för att förlora dina pengar.

We've got a full squad back this week as Sobi, Pink, and Bart are all in the house. We catch up on what's been going on lately, the crazy spring/summer we've had, and of course the fishing adventures that have been taking place. Then, we catch up on the Sporting World, as Bart brings a bunch of different noteworthy topics to the forefront. Also, we're definitely a Wolves Podcast.We dive into a BUNCH of PTB fan questions, which eventually leads us down a worm hole addressing Tourney Tuesday, the Classic Bass Champions Tour, and the punishment that Sobi keeps avoiding. As we then address our guest for the show.This brings us to catching up on the Bassmaster World, and how our Fantasy Fishing lineups are doing; a little bit of "What You Been Drinking?" and ultimately ending with a pretty incredible 1v1.Strap in! You know you're in for a good one.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Strap in!!!We are back for another Episode of Past The Barb, Pinkalla and Sobi are joined by a PTB frequent flyer Hays Baldwin. We are quickly approaching the Minnesota fishing opener and they boys are making some plans.Pinkalla is fresh off a Great Lakes walleye trip to Green Bay, and Sobi and Hays have been up to no good. Must have essentials for opening weekend, current predictions of best places to smash walleyes in the state, and they fellas round this one out with an all-new Weigh-In: of The Worst things about Technology. Don't miss a moment of this one! ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

Naš najbolj prijazen pokrovitelj T2 in njihova super ponudba King:https://www.t-2.net/paketi/oranzni-king-----------------------------------------------------------Fejmrč na https://www.fejmici.si/Vaše težave: podcast.fejmici@gmail.comPoljubna enkratna donacija na: ⁠https://tinyurl.com/y2uyljhm⁠Mesečna finančna podpora možna na:3€ - ⁠https://tinyurl.com/yxrkqgbc⁠5€ - ⁠https://tinyurl.com/y63643l5⁠8€ - ⁠https://tinyurl.com/y62ywkmt⁠Motitelji:- Gašper Bergant⁠https://www.gasperbergant.si ⁠⁠https://www.instagram.com/gasper.bergant/  ⁠- Žan Papič⁠https://www.zanpapic.si ⁠⁠https://www.instagram.com/zanpapi/  ⁠Produkcija: Warehouse Collective⁠https://www.warehousecollective.si⁠Grafična podoba: Artex⁠https://www.facebook.com/artextisk

The boys have been on a tear lately and we hope you've enjoyed the influx of Episodes! This week we've got Pinkalla and Sobi manning the ship, as Bart is out of town. The boys catch up on what they've been up to lately, Spring has Sprung in the north and Open Water is here!We dive into a little bit of "Bart Sports" even with him absent, because you can't NOT talk about Ovi breaking the NHL All-Time Goals record, and we give a little bit of Bassmaster Fantasy fishing insight to an intriguing event kicking off this week.Then for a bulk of the show we are joined by NWT Pro's Hunter Nitti and Will Pappenfus. These young guys have been smashing on the tour lately, including Hunter winning AOY last year; and if you know anything about their crew, they like to have FUN.Hang on tight folks, this one is a doozy!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We've got a full squad back on the Podcast this week! Sobi is back from being on the road squeezing every last second of life out of the Ice Fishing Season. The boys all catch up on what they've been up to lately, and do a little Bassmaster Classic preview as well as a Fantasy Fishing Update.We then bring on a friend of ours, NFL Center Frank Ragnow, to chat about an incredible adventure he took into the Canadian Wilderness with Jason Mitchell to fish an UNTOUCHED Lake in Northern Saskatchewan. Hearing about this trip is absolutely epic, and we catch up with Frank about a bunch of other stuff he's done in the fishing and outdoors world. Frank is an A+ human being and it's impossible not to feel his love for the outdoors.After our interview we talk a little bit about what's been going on in the world, as well as preview an award we want to follow more closely, Carl Jocumsen's "Fear My Heart" award. We then end with a good 'ol segment of The Weigh In, this time we're talking the Best Frozen Pizza's.Strap in!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We are back once again for another Podcast! Sobi is still out of the office at the moment chasing some last minute ice fishing videos, but Bart and Pink hold down the fort with our special guest, Maggie Carsello.The crew dives into what they've been up to lately, including recent ice fishing adventures. We chat a bit about Bassmaster Fantasy and the beginning of the Tournament Bass Season, then dive into some Turkey Hunting talk. After a bunch of shenanigans and fun times, we get into some PTB Fan Questions to end the night.A nice laid back episode, with some fun BSing and catching up.~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

The boys are BACK! Pinkalla and Bart host the show and immediately bring in a special guest, Elite Series Rookie Blake Capps. Blake is a hammer from Oklahoma and is a friend of Bart and Sobi's from way back in the day. We chatted with him about making the Elites, what his prep has been like, and some good 'ol Oklahoma stories that would make Jason Christie happy.Then we bring in Waldo and Griff to round out the whole crew from The Crappie Chronicles and dive into a bunch of stories from the season thus far, as well as a sneak peak into their most recent trip that will hit YouTube soon.This is a fun one!~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.comInstagram: @pastthebarbpodcastFacebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We've got Sobi, Bart, and Pinkalla back this week catching up on everything that's been going on. The Vikings Season is over, everyone is sick, and the Ice Season is in full swing. Then we have our friend, Clayton Schick on the Podcast for a long awaited interview. This is a fantastic episode and a great chat between this crew! ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

HAPPY NEW YEAR from the whole crew at PTB! This week the boys catch up on how everything went over the holidays and what has been going on out on the ice. Pinkalla, Bart and Sobi lead off the year, Sobi has contracted an illness and is staying in isolation. They take a trip down memory lane a dive into some of their favorite trips and catches from 2024. Everyone's got some lofty new years resolutions dialed up, 2025 is going to be a big year for all they PTB boys. Answers to some burning questions from listeners and some good ol fashioned shenanigans in this one!! Grab a cold one and strap in!!

Happy Thanksgiving from all the PTB boys!! This week with a full house Pinkalla, Bart, Sobi and, Capt Bill breakdown changing over to winter mode. There's still been a lot of hunting action going down all across PTB country. This ones got everything from Livescoping deer, to punching elk tags. The boys get into their dream trophy rooms and there's a lot of hype for the St.Paul ice show! Pinkalla had a little mishap that lead to a police chase......and it pretty much goes off he rail from there. Rounding out this episode is an all new 1v1v1 of head to head Thanksgiving trivia that's going to make you want to drive off the road.

We've got a bonus Episode for the fans of the # 1 Outdoor Podcast in the game! Bart, Sobi, Hahner, and Pinkalla hop on for an extended Episode where we catch up with a longtime buddy in the fishing industry, Ben Milliken. This one is a doozy, so strap in and enjoy this Episode! ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

We've got a packed house tonight as Bart, Sobi, Stolski, and Hahner bring a new Episode to you while Pinkalla is out west on a hunt. The boys catch up on what's been going on their lives, including Hahner helping a young angler catch the muskie bug! We then dive into a loaded segment of PTB Fan Questions where we get to the nitty gritty of a bunch of stuff our listeners want to know. Then we bring in a new face to the Podcast, accompanied by our friend Hays Baldwin. We dive into the brain of Buddy Jaron Clinch as he's taken the Outdoor Industry by storm over the past year, bringing comedy to a space that lacks it. We chat about his rise on Instagram and TikTok, his recent travels, and where he hopes to be in the coming months and years. We end with a festive segment of The Weigh In. The boys have a loaded draft featuring the Worst Halloween Candy. ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

In this episode of the Ice Team Podcast we go off on all sorts of tangents… and in a good way!!  Matt sits down with three social media influencers, all of which have amazing stories to tell… Sam “Sobi” Sobieck, Adam “Bart” Bartusek, and Tyler Brick.  Strap in for this one, let's have some fun!! #iceteam #iceteamfishing #iceteampodcast

We've got another Episode of Past The Barb and it's the return of Cody Hahner, who's joined by Bart and Sobi. The boys catch up on what's been going on in their lives, Sobi has been sitting in a tree a bit, Hahner's garden was ultra successful, and Bart has been laying low. BartStool Sports checks in on the Vikings being 5-0 but honestly we're all just impressed with how good the NFC North is right now. It's going to be a crazy tough year in the NFL but it's a fun time to be a fan. Then, the return of our friend Hays Baldwin, for the long awaited return of Trivia With Hays. We then get into an interview with a returning guest, Easton Fothergill, who just finished up winning the Bassmaster Opens EQ Angler of the Year and qualified for the Elite Series. We wrap up with a little Podcast with another segment of The Weigh In, this time we're chatting the "Most OG Lures in Bass Fishing". ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

In today's episode, supported by Sobi, we had the pleasure of speaking with Aaron T. Gerds, MD, MS, and James K. McCloskey, MD, about myelofibrosis treatment advances. Dr Gerds is an assistant professor in the Department of Medicine in the School of Medicine, as well as a member of the Developmental Therapeutics Program at the Case Comprehensive Cancer Center in Cleveland, Ohio. He is also a physician in the Department of Hematology and Medical Oncology at Cleveland Clinic. Dr McCloskey is the interim chief of the Division of Leukemia at Hackensack John Theurer Cancer Center in New Jersey.  In our exclusive interview, Drs Gerds and McCloskey discussed factors that influence their choice between the variety of JAK inhibitors that are FDA approved for patients with myelofibrosis, tips for symptom management in this disease, and emerging myelofibrosis research to look out for. 

The boys are back for another episode of Past The Barb and we've got a full house. We're joined by Pinkalla, Bart, Sobi, & Stolski is back from his truck breaking down and ready to raise some hell. We catch up a little bit on everything that's been going on in our lives, finishing up tournament season, and the prep for Hunting season has begun. We jump into a couple short segments, including BARTstool Sports where we chat about the death of Pete Rose, the Twins choking away a playoff birth, and the Bart is once again, all in on the Minnesota Vikings. We are then joined by our good buddy, Tyler Brick, He walks us through a monster early season buck he just killed in Northern Minnesota that is going to be featured in Deer Society. We dive into his trek around the United States with Mystery Tackle Box living in a 40 ft Largemouth Bass for over 21 months, and all other things going on in his life. We wrap this Episode up with another fun little game. This time we've got 1v1v1v1 deciding the question we've all wondered "JDM Bait" or "Japanese Sex Toy". You won't want to miss this one! ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing

It's time for another Episode of Past The Barb! As we head into the fall season we are getting back in the swing of things being more prepared with segments, interviews, and relevant topics. We're joined by Sobi, Bart, and Pinkalla to get this Episode rolling and they give the deets on a big GIVEAWAY PTB is doing for the fans. After catching up on what's been going on in our lives, we're joined by Maggie Carsello for another segment of "Fresh Meat", where we catch up with her about her season fishing the Bassmaster Opens and how she felt the BassmastHer campaign went. Quickly we dive into a little bit of sports discussion with Bart, but then we bring in our special guest of the show Chancy Walters, from Whitetail Adrenaline. Chancy is a unique individual with a strong history of artistic creativity in the outdoors. His passion for hunting brought him to some crazy adventures filming Whitetail Adrenaline and going international on his first trip to Africa. This interview is loaded with Hunting, Fishing, and creative Arts. It's a fun one! Then we bring it home with a little bit of PTB Fan questions. ~ Past The Barb Social Media ~ Email Us Questions and Feedback: pastthebarbpodcast@gmail.com Instagram: @pastthebarbpodcast Facebook: https://www.facebook.com/profile.php?... ~ Follow Us On Social Media ~ Adam Bartusek Instagram: @adambartusek Adam Bartusek Facebook: https://www.facebook.com/adambartbart... Ryan Pinkalla Instagram: @ryan_pinkalla Ryan Pinkalla YouTube: https://www.youtube.com/channel/UCiRa... Will Stolski Instagram: @will_stolski Cody Hahner Instagram: @codyhahnerfishing Sam Sobi Instagram: @sam_sobi_ Sam Sobi Facebook: https://www.facebook.com/sobieckfishing